Access to better tolerated, more convenient regimens for HIV treatment promotes adherence and leads to better patient outcomes. CHAI is working to ensure affordable pricing and to address demand-side barriers to access. Increased uptake of optimal second-line regimens in Uganda and Nigeria has improved HIV treatment and will deliver US$6.5 million in savings by 2018. Learn more about this work to improve HIV treatment outcomes for patients on second-line therapy through optimal regimen uptake in this case study.
